nb-598 and Hyperlipidemias

nb-598 has been researched along with Hyperlipidemias* in 1 studies

Reviews

1 review(s) available for nb-598 and Hyperlipidemias

Article	Year
[Other antihyperlipidemic drugs with novel mechanism]. Nihon rinsho. Japanese journal of clinical medicine, 2001, Volume: 59 Suppl 3 Topics: Animals; Arteriosclerosis; Azetidines; Benzylamines; Carrier Proteins; CCAAT-Enhancer-Binding Proteins; Chenodeoxycholic Acid; Cholesterol; Coronary Disease; Diphosphonates; DNA-Binding Proteins; Ezetimibe; Farnesyl-Diphosphate Farnesyltransferase; Humans; Hyperlipidemias; Hypolipidemic Agents; Lithocholic Acid; Organic Anion Transporters, Sodium-Dependent; Oxygenases; Squalene Monooxygenase; Sterol Regulatory Element Binding Protein 1; Symporters; Thiophenes; Transcription Factors	2001

Article

Year

[Other antihyperlipidemic drugs with novel mechanism].

Nihon rinsho. Japanese journal of clinical medicine, 2001, Volume: 59 Suppl 3

Topics: Animals; Arteriosclerosis; Azetidines; Benzylamines; Carrier Proteins; CCAAT-Enhancer-Binding Proteins; Chenodeoxycholic Acid; Cholesterol; Coronary Disease; Diphosphonates; DNA-Binding Proteins; Ezetimibe; Farnesyl-Diphosphate Farnesyltransferase; Humans; Hyperlipidemias; Hypolipidemic Agents; Lithocholic Acid; Organic Anion Transporters, Sodium-Dependent; Oxygenases; Squalene Monooxygenase; Sterol Regulatory Element Binding Protein 1; Symporters; Thiophenes; Transcription Factors

2001